Selected article for: "cardiovascular disease and disease state"

Author: Landstra, Cyril P.; de Koning, Eelco J. P.
Title: COVID-19 and Diabetes: Understanding the Interrelationship and Risks for a Severe Course
  • Cord-id: jzeaabwo
  • Document date: 2021_6_17
  • ID: jzeaabwo
    Snippet: The relationship between COVID-19 and diabetes mellitus is complicated and bidirectional. On the one hand, diabetes mellitus is considered one of the most important risk factors for a severe course of COVID-19. Several factors that are often present in diabetes mellitus are likely to contribute to this risk, such as older age, a proinflammatory and hypercoagulable state, hyperglycemia and underlying comorbidities (hypertension, cardiovascular disease, chronic kidney disease and obesity). On the
    Document: The relationship between COVID-19 and diabetes mellitus is complicated and bidirectional. On the one hand, diabetes mellitus is considered one of the most important risk factors for a severe course of COVID-19. Several factors that are often present in diabetes mellitus are likely to contribute to this risk, such as older age, a proinflammatory and hypercoagulable state, hyperglycemia and underlying comorbidities (hypertension, cardiovascular disease, chronic kidney disease and obesity). On the other hand, a severe COVID-19 infection, and its treatment with steroids, can have a specific negative impact on diabetes itself, leading to worsening of hyperglycemia through increased insulin resistance and reduced β-cell secretory function. Worsening hyperglycemia can, in turn, adversely affect the course of COVID-19. Although more knowledge gradually surfaces as the pandemic progresses, challenges in understanding the interrelationship between COVID-19 and diabetes remain.

    Search related documents:
    Co phrase search for related documents
    • ace inhibitor and acute respiratory distress syndrome: 1, 2, 3, 4, 5
    • ace inhibitor and additional risk: 1
    • ace inhibitor and adjusted hr: 1, 2
    • ace inhibitor and adjusted risk: 1, 2
    • ace inhibitor and admission time: 1
    • ace inhibitor and lung function: 1, 2
    • ace inhibitor and lung injury: 1, 2, 3, 4
    • ace inhibitor and lymphocyte count: 1
    • acute illness and additional analysis: 1
    • acute illness and adjusted risk: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
    • acute illness and admission cancer: 1, 2
    • acute illness and admission time: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
    • acute illness and liver disease: 1, 2, 3, 4, 5, 6
    • acute illness and liver kidney: 1, 2, 3, 4
    • acute illness and lockdown period: 1, 2
    • acute illness and long duration: 1, 2
    • acute illness and long unclear: 1
    • acute illness and low prevalence: 1, 2, 3, 4, 5
    • acute illness and lung function: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10